LP
DRTSW icon

LMR Partners’s Alpha Tau Medical Warrant DRTSW Stock Holding History

LMR Partners’s Portfolio DRTSW Stock Details DRTSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-112,986
Closed -$21.5K – 1307
2024
Q3 		$21.5K Buy
+112,986
New +$23.3K ﹤0.01% 1115

Other funds holding DRTSW

FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
MCM
Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $7.65B AUM 13.87% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return
CWM
Circle Wealth Management Summit, New Jersey $7.96B AUM 30.85% 1-Year Est. Return

LMR Partners's DRTSW Position: Q2 2026 in Review

LMR Partners increased its Alpha Tau Medical Warrant (DRTSW) stake by 265% in Q2 2026, buying an estimated $1.81M and bringing the position to 1,494,631 shares worth $4.41M. The position accounts for 0.02% of the portfolio, ranked #697.

LMR Partners first reported a position in DRTSW in Q1 2022 and has held it in 17 quarters since. 21 funds tracked by Wall St. Rank hold DRTSW as of Q2 2026.

  • LMR Partners held 1,494,631 shares of Alpha Tau Medical Warrant worth $4.41M as of Q2 2026.
  • LMR Partners bought 1,084,984 Alpha Tau Medical Warrant shares in Q2 2026, an estimated $1.81M.
  • Alpha Tau Medical Warrant made up 0.02% of LMR Partners's portfolio in Q2 2026, its #697 holding.
  • LMR Partners first reported a position in Alpha Tau Medical Warrant in Q1 2022 and has held it in 17 quarters since.
  • 21 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q2 2026.

Based on LMR Partners's 13F filing for Q2 2026, filed 14 Aug 2026.